Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael I Ellenbogen

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of General Internal Medicine|February 13, 2023
Reducing Overuse by Healthcare Systems: A Positive Deviance AnalysisMichael I Ellenbogen, Aaron A Wiegand, J Matthew Austin, et al.
Thrombosis Research|December 5, 2022
Healthcare utilization differences between an apixaban-based and warfarin-based strategy for acute venous thromboembolism in patients with end-stage kidney diseaseShirin Ardeshirrouhanifard, Michael I Ellenbogen, Jodi B Segal, et al.
Drugs & Aging|November 30, 2019
Frequency and Predictors of Polypharmacy in US Medicare Patients: A Cross-Sectional Analysis at the Patient and Physician LevelsMichael I Ellenbogen, Peiqi Wang, Heidi N Overton, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of General Internal Medicine|February 13, 2023
Reducing Overuse by Healthcare Systems: A Positive Deviance AnalysisMichael I Ellenbogen, Aaron A Wiegand, J Matthew Austin, et al.
Thrombosis Research|December 5, 2022
Healthcare utilization differences between an apixaban-based and warfarin-based strategy for acute venous thromboembolism in patients with end-stage kidney diseaseShirin Ardeshirrouhanifard, Michael I Ellenbogen, Jodi B Segal, et al.
Drugs & Aging|November 30, 2019
Frequency and Predictors of Polypharmacy in US Medicare Patients: A Cross-Sectional Analysis at the Patient and Physician LevelsMichael I Ellenbogen, Peiqi Wang, Heidi N Overton, et al.
Pageof 3